FDA, COVID and Heart Risk
Digest more
Top News
Overview
Impacts
Cardiovascular issues are common, and now some experts term severe COVID an independent coronary artery disease risk factor needing aggressive management.
A pharmaceutical-grade cannabidiol (CBD) product was shown to be safe in high-risk patients hospitalized with COVID-19, with no increased rate of cardiac side effects compared with placebo.
14h
News-Medical.Net on MSNIntegrating phytomedicine and nanotechnology in managing COVID-19 related heart diseaseAcute coronary syndrome (ACS) in patients with SARS-CoV-2 infection represents a critical intersection of viral-induced inflammation and cardiovascular pathology.
Top federal health officials actively took steps to “delay warning the public” for months in 2021 about the potential risks of heart-related complications from receiving mRNA COVID-19 vaccines ...